Advertisement
No access
Report

A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent Neuropeptide

Science
23 Sep 1983
Vol 221, Issue 4617
pp. 1310-1312

Abstract

A peptide that accumulated as the major product during the proteolysis of arginine vasopressin by rat brain synaptic membranes was isolated and its structure was shown to be the hexapeptide pGlu-Asn-Cys(Cys)-Pro-Arg-Gly-NH2. When administered intracerebroventricularly in extremely low doses, this vasopressin fragment and its desglycinamide derivative facilitated memory consolidation in a passive avoidance situation. These vasopressin metabolites, which are devoid of pressor activity, constitute highly potent neuropeptides with selective effects on memory and related processes; they are activated via proteolytic processing of vasopressin by brain peptidases.

Get full access to this article

View all available purchase options and get full access to this article.

References

ADER, R, RETENTION OF A PASSIVE AVOIDANCE RESPONSE AS A FUNCTION OF INTENSITY AND DURATION OF ELECTRIC SHOCK, PSYCHONOMIC SCIENCE 26: 125 (1972).
ADER, R, EFFECTS OF LYSINE VASOPRESSIN ON PASSIVE AVOIDANCE-LEARNING, PSYCHONOMIC SCIENCE 29: 46 (1972).
BOHUS, B, EFFECT OF LYSINE VASOPRESSIN AND ACTH4-10 ON CONDITIONED AVOIDANCE BEHAVIOR OF HYPOPHYSECTOMIZED RATS, NEUROENDOCRINOLOGY 11: 137 (1973).
BURBACH, JPH, PROTEOLYTIC CONVERSION OF BETA-ENDORPHIN BY BRAIN SYNAPTIC-MEMBRANES - CHARACTERIZATION OF GENERATED BETA-ENDORPHIN FRAGMENTS AND PROPOSED METABOLIC PATHWAY, JOURNAL OF BIOLOGICAL CHEMISTRY 256: 2463 (1981).
BURBACH, JPH, PROTEOLYTIC CONVERSION OF ARGININE-VASOPRESSIN AND OXYTOCIN BY BRAIN SYNAPTIC-MEMBRANES - CHARACTERIZATION OF FORMED PEPTIDES AND MECHANISMS OF PROTEOLYSIS, JOURNAL OF BIOLOGICAL CHEMISTRY 258: 1487 (1983).
BURBACH, JPH, SENSITIVE AND RAPID AMINO-ACID-ANALYSIS OF PEPTIDE HYDROLYSATES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ORTHO-PHTHALDIALDEHYDE DERIVATIVES, JOURNAL OF CHROMATOGRAPHY 237: 339 (1982).
BURBACH, JPH, NEUROPHYPOPHYSEAL PE: 69 (1981).
CELESTIAN, J.F., UNIMPAIRED MAINTENANCE OF A CONDITIONED AVOIDANCE-RESPONSE IN RAT WITH DIABETES-INSIPIDUS, PHYSIOLOGY & BEHAVIOR 15: 707 (1975).
COOPER, K. E., JOURNAL OF PHYSIOLOGY-LONDON 295: 33 (1979).
DEBOER, G.J., PROGRESS IN BRAIN RESEARCH 53: 207 (1980).
DEKANSKI, J, THE QUANTITATIVE ASSAY OF VASOPRESSIN, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 7: 567 (1952).
DEWIED, D, MEMORY DEFICIT IN RATS WITH HEREDITARY DIABETES-INSIPIDUS, BRAIN RESEARCH 85: 152 (1975).
DEWIED, D, DISSOCIATION OF BEHAVIORAL AND ENDOCRINE EFFECTS OF LYSINE VASOPRESSIN BY TRYPTIC DIGESTION, BRITISH JOURNAL OF PHARMACOLOGY 45: 118 (1972).
DEWIED, D, FRONT NEUROENDOCRIN: 97 (1969).
DEWIED, D, LONG TERM AND SHORT TERM EFFECTS ON RETENTION OF A CONDITIONED AVOIDANCE RESPONSE IN RATS BY TREATMENT WITH LONG ACTING PITRESSIN AND ALPHA-MSH, NATURE 212: 1484 (1966).
DEWIED, D, LONG TERM EFFECT OF VASOPRESSIN ON MAINTENANCE OF A CONDITIONED AVOIDANCE RESPONSE IN RATS, NATURE 232: 58 (1971).
DEWIED, D, BEHAVIORAL ACTIONS OF NEUROHYPOPHYSEAL PEPTIDES, PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 210: 183 (1980).
DEWIED, D, PROGRESS IN BRAIN RESEARCH 48: 327 (1978).
DOOLITTLE, R.F., PYRROLIDONYL PEPTIDASE . AN ENZYME FOR SELECTIVE REMOVAL OF PYRROLIDONECARBOXYLIC ACID RESIDUES FROM POLYPEPTIDES, BIOCHEMISTRY 7: 516 (1968).
FLEXNER, J.B., DOSE-RESPONSE RELATIONSHIPS IN ATTENUATION OF PUROMYCIN-INDUCED AMNESIA BY NEUROHYPOPHYSEAL PEPTIDES, BRAIN RESEARCH 134: 139 (1977).
FLEXNER, J.B., ADH AND RELATED PEPTIDES - EFFECT OF PRETRAINING OR POSTTRAINING TREATMENT ON PUROMYCIN AMNESIA, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 8: 93 (1978).
GOLD, P.W., EFFECTS OF 1-DESAMO-8-D-ARGININE VASOPRESSIN ON BEHAVIOR AND COGNITION IN PRIMARY AFFECTIVE-DISORDER, LANCET 2: 992 (1979).
GRAY, W.R., RAPID SEQUENCE ANALYSIS OF SMALL PEPTIDES, ANALYTICAL BIOCHEMISTRY 33: 36 (1970).
HOFFMAN, P.L., NEUROHYPOPHYSEAL PEPTIDE INFLUENCES ON ETHANOL TOLERANCE AND ACUTE EFFECTS OF ETHANOL, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 13: 279 (1980).
Jolles, J., Progress in Brain Research, in press.
Laczi, F., Psychoneuroendocrinology 7: 185 (1982).
LEBOEUF, A, VASOPRESSIN AND MEMORY IN KORSAKOFF SYNDROME, LANCET 2: 1370 (1978).
LEGROS, J.J., INFLUENCE OF VASOPRESSIN ON LEARNING AND MEMORY, LANCET 1: 41 (1978).
NARITA, K, MOL BIOL BIOCH BIOPH 8: 30 (1975).
OLIVEROS, J.C., VASOPRESSIN IN AMNESIA, LANCET 1: 42 (1978).
PFEIFER, W.D., VASOPRESSIN ANTAGONIZES RETROGRADE-AMNESIA IN RATS FOLLOWING ELECTROCONVULSIVE SHOCK, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 9: 261 (1978).
PODELL, D.N., TECHNIQUE FOR REMOVAL OF PYROGLUTAMIC ACID FROM AMINO TERMINUS OF PROTEINS USING CALF LIVER PYROGLUTAMATE AMINO PEPTIDASE, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 81: 176 (1978).
RIGTER, H, EFFECTS OF PEPTIDES RELATED TO NEUROHYPOPHYSEAL HORMONES ON ETHANOL TOLERANCE, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 13: 285 (1980).
RIGTER, H, EFFECTS OF ACTH-ANALOGS AND VASOPRESSIN-ANALOGS ON CO2-INDUCED RETROGRADE-AMNESIA IN RATS, PHYSIOLOGY & BEHAVIOR 13: 381 (1974).
VANREE, J.M., ENDOGENOUS PEPTIDES: 397 (1981).
VERSTEEG, CAM, APPROACH HYPERTENSIV: 329 (1979).
WALTER, R, POLYPEPTIDE HORMONES: 321 (1980).
WEINGARTNER, H, VASOPRESSIN TREATMENT OF COGNITIVE DYSFUNCTION IN PROGRESSIVE DEMENTIA, LIFE SCIENCES 29: 2721 (1981).
WEINGARTNER, H, EFFECTS OF VASOPRESSIN ON HUMAN-MEMORY FUNCTIONS, SCIENCE 211: 601 (1981).
WITTER, A, H-PRO-[H-3]LEU-GLY-NH2 - METABOLISM IN HUMAN AND RAT PLASMA INVESTIGATED BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY, NEUROENDOCRINOLOGY 30: 377 (1980).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 221 | Issue 4617
23 September 1983

Submission history

Published in print: 23 September 1983

Permissions

Request permissions for this article.

Authors

Affiliations

J. Peter H. Burbach
Rudolf Magnus Institute for Pharmacology, University of Utrecht Medical Faculty, Vondellaan 6, 3521 GD Utrecht, Netherlands
Gabor L. Kovacs
Rudolf Magnus Institute for Pharmacology, University of Utrecht Medical Faculty, Vondellaan 6, 3521 GD Utrecht, Netherlands
David de Wied
Rudolf Magnus Institute for Pharmacology, University of Utrecht Medical Faculty, Vondellaan 6, 3521 GD Utrecht, Netherlands
Jan W. van Nispen
Scientific Development Group, Organon Int. B.V., 5340 BH Oss, Netherlands
Henk M. Greven
Scientific Development Group, Organon Int. B.V., 5340 BH Oss, Netherlands

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media